HCT/P Documentation Checklist

1. Donor Eligibility Documentation

Donor eligibility documentation provides information concerning donor screening, donor testing, and the donor eligibility determination under applicable requirements in 21 CFR Part 1271 Subpart C.

Reviewing these materials can help healthcare professionals understand the donor eligibility information represented within the documentation package and identify questions or areas requiring clarification.

• ☐ Donor eligibility determination documentation
• ☐ Donor screening information
• ☐ Communicable disease testing information
• ☐ Relevant laboratory information associated with donor testing
• ☐ Medical and behavioral risk information, where applicable
• ☐ Supporting donor records or summaries made available for review

Reference: Donor Eligibility Under 21 CFR Part 1271

2. Processing & Handling Documentation

Processing documentation provides educational context regarding how human cells or tissues are recovered, processed, preserved, handled, packaged, stored, labeled, or prepared for distribution.

Reviewing these records helps professionals understand the processing represented in the available documentation and identify information that may be relevant to regulatory concepts such as minimal manipulation.

• ☐ Description of processing methods
• ☐ Preservation procedures
• ☐ Storage requirements
• ☐ Handling procedures
• ☐ Environmental controls or monitoring information, where applicable
• ☐ Packaging information
• ☐ Lot or batch identification information
• ☐ Product specifications or other relevant technical documentation

Reference: Minimal Manipulation

Educational review should focus on understanding the processing described in the documentation. Processing records alone should not be treated as establishing whether a particular regulatory criterion has been satisfied.

3. Intended Use & Product Description

Product descriptions, labeling, and intended-use information can provide important context during documentation review. Understanding how an HCT/P is described and the intended function represented in the documentation can help professionals identify regulatory concepts that may require further evaluation.

• ☐ Product labeling and description
• ☐ Intended-use statement
• ☐ Relevant instructions for use, when applicable
• ☐ Description of the tissue's basic function or functions
• ☐ Supplier statements concerning homologous use, when provided
• ☐ Supplier statements concerning structural or cellular/nonstructural tissue characteristics, when provided
• ☐ Consistency of intended-use language across available documentation

References: Homologous Use and Structural vs. Cellular Tissue

Supplier descriptions and labeling should be evaluated together with applicable regulatory requirements and other relevant facts. Documentation or promotional language alone does not determine regulatory classification.

4. Current Good Tissue Practice (cGTP) & Quality Documentation

Current Good Tissue Practice requirements are addressed in 21 CFR Part 1271 Subpart D. Reviewing available cGTP- and quality-related documentation can help healthcare professionals understand procedures, controls, records, and quality-system practices represented by the supplier or responsible organization.

The specific documentation available may vary according to the organization, HCT/P, activities performed, and applicable regulatory requirements.

• ☐ Quality procedures or quality-system information
• ☐ Procedures relevant to applicable processing or handling activities
• ☐ Storage controls
• ☐ Distribution controls
• ☐ Environmental controls or monitoring information, where applicable
• ☐ Tracking procedures
• ☐ Recordkeeping procedures
• ☐ Complaint procedures, where applicable
• ☐ Corrective-action documentation, when applicable and available
• ☐ Other supporting quality documentation relevant to the evaluation

Reference: Current Good Tissue Practice (cGTP)

5. Chain of Custody & Traceability

Traceability documentation supports understanding of how an HCT/P is identified and tracked through relevant stages such as recovery, processing, storage, shipment, distribution, and receipt.

Reviewing traceability records can help professionals understand documentation continuity and identify gaps or transitions that may require clarification.

• ☐ Unique identifier, lot number, or other tracking identifier
• ☐ Chain-of-custody documentation
• ☐ Product identification records
• ☐ Storage information or logs, where applicable
• ☐ Shipping documentation
• ☐ Distribution records
• ☐ Receiving information, where available and relevant
• ☐ Consistency of identifiers across related documentation

Reference: Chain of Custody & Traceability

Traceability documentation should be reviewed together with donor eligibility, processing, quality, and other relevant documentation to understand its role within the broader documentation package.

6. Establishment & Regulatory Information

Publicly available regulatory information and supplier-provided regulatory documentation can provide important context during professional review. These sources should be distinguished from one another and interpreted according to their respective roles.

• ☐ FDA establishment registration information, where applicable
• ☐ HCT/P listing information, where applicable
• ☐ Supplier statements regarding regulatory pathway or classification
• ☐ Applicable regulatory references identified in supplier documentation
• ☐ Publicly available FDA inspection or compliance information, where relevant
• ☐ Product labeling and regulatory statements reviewed for consistency

Reference: FDA Establishment Registration

7. Overall Documentation Review

After reviewing each documentation category, consider the available package collectively. The objective is to understand what information is available, how the records relate to one another, where limitations exist, and which questions remain unresolved.

• ☐ Regulatory context reviewed
• ☐ Donor eligibility documentation reviewed
• ☐ Processing and handling documentation reviewed
• ☐ Intended-use and product-description information reviewed
• ☐ cGTP and quality documentation reviewed
• ☐ Chain-of-custody and traceability information reviewed
• ☐ Establishment and regulatory information reviewed
• ☐ Related documents checked for internal consistency
• ☐ Supplier representations distinguished from regulatory requirements
• ☐ Missing information or limitations identified
• ☐ Questions requiring clarification documented
• ☐ Available documentation considered as a complete package

Using This Checklist Effectively

A documentation checklist is most valuable when used as part of a structured review methodology rather than as a simple list of documents to collect.

Documentation should be evaluated collectively to understand how regulatory information, donor eligibility records, processing documentation, intended-use information, quality systems, traceability records, and supporting materials relate to one another within the overall documentation package.

No single document should automatically be treated as determining regulatory status, product quality, clinical performance, or supplier suitability. Each category contributes a different type of information to the professional evaluation.

What This Checklist Does Not Do

A structured checklist can improve consistency, but its limitations are equally important.

• It does not determine whether an HCT/P qualifies for regulation solely under Section 361 of the Public Health Service Act and 21 CFR Part 1271.
• It does not determine whether an HCT/P is regulated under Section 351.
• It does not certify regulatory compliance.
• It does not validate supplier representations.
• It does not approve or reject supplier documentation.
• It does not rank or recommend suppliers or participating organizations.
• It does not determine product quality, safety, effectiveness, or clinical appropriateness.
• It does not replace independent legal, regulatory, scientific, purchasing, or clinical judgment.

Continue Your Documentation Review

This checklist is one component of the broader Supplier Documentation Knowledge Center. The following educational resources expand the documentation-first methodology and provide additional context for structured professional evaluation.

• HCT/P Supplier Evaluation Process — Follow the complete documentation-review journey.
• HCT/P Supplier Documentation Evaluation Framework — Understand the methodology connecting the major documentation categories.
• Documentation Transparency — Examine organization, clarity, availability, consistency, and context.
• Requesting HCT/P Supplier Documentation — Learn how to identify and request relevant available documentation.
• Questions to Ask an HCT/P Supplier — Use structured documentation-focused questions.
• Compare HCT/P Documentation — Compare documentation consistently without ranking suppliers.
• Common Documentation Review Mistakes — Identify common errors that can weaken professional review.
• HCT/P Documentation FAQ — Review frequently asked documentation questions.
• HCT/P Documentation Glossary — Review terminology used throughout this educational system.

From Education to Professional Evaluation

The Not By Chance Life Knowledge Center provides the educational layer for understanding HCT/P regulations, documentation categories, documentation transparency, and structured documentation-review methodology.

When a qualified healthcare professional is ready to move from education into an active professional evaluation, NBCL Connect provides a separate professional workflow environment.

Frequently Asked Questions

Does this checklist determine regulatory compliance?

No. This checklist is an educational organizational tool intended to support structured documentation review. It does not determine regulatory classification or compliance.

Does completing every checklist item establish Section 361 status?

No. Completing this checklist does not establish that an HCT/P satisfies the criteria for regulation solely under Section 361 of the Public Health Service Act and 21 CFR Part 1271. Regulatory classification depends on the applicable legal and regulatory framework and the relevant facts.

Should every supplier provide identical documentation?

No. Documentation packages may differ depending on the HCT/P, activities performed, applicable regulatory requirements, organizational practices, and circumstances of the evaluation. This checklist identifies educational review categories rather than creating a universal list of documents that every supplier must provide.

Does FDA establishment registration indicate FDA approval?

No. FDA establishment registration under 21 CFR Part 1271 does not constitute FDA approval, clearance, endorsement, certification, or an FDA determination regarding product safety or effectiveness.

Does a Certificate of Analysis establish the complete regulatory picture?

No. A Certificate of Analysis may provide product- or lot-specific analytical information, depending on the document, but it should be interpreted according to its contents and limitations and within the broader documentation package. It does not independently establish regulatory classification or compliance.

Should scientific publications be included in the same category as regulatory documentation?

No. Scientific literature may provide useful biological or scientific context, but scientific evidence and regulatory documentation serve different purposes. Scientific publications should not be presented as independently determining regulatory classification.

Can missing documentation automatically be treated as regulatory noncompliance?

Not necessarily. The absence of a particular document from the materials available to a reviewer does not by itself establish regulatory noncompliance. The reviewer should identify the limitation, consider whether the document is applicable, and request clarification where appropriate.

Does Not By Chance Life approve documentation reviewed through this checklist?

No. Not By Chance Life provides regulatory education, documentation guidance, scientific education, provider education, documentation-transparency resources, and professional evaluation infrastructure. It does not approve supplier documentation or certify participating organizations.

Can this checklist be used with NBCL Connect?

Yes. This educational checklist can help qualified professionals organize their own documentation review. NBCL Connect separately provides professional workflow infrastructure for evaluation and communication with participating organizations. Use of the checklist or NBCL Connect does not constitute NBCL approval of an organization, its documentation, or a product.

Who should use this checklist?

This educational resource is intended for licensed healthcare professionals, healthcare organizations, compliance personnel, procurement teams, researchers, and other qualified professionals evaluating HCT/P supplier documentation.

Professional Access

Qualified healthcare professionals who are ready to move from documentation education into an active professional evaluation can learn about professional access or proceed to NBCL Connect.

Professional Access Information →

Access NBCL Connect →

Regulatory & Educational Notice

Not By Chance Life LLC provides regulatory education, documentation guidance, scientific education, provider education, educational resources, documentation transparency, and professional evaluation infrastructure related to Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps).

This checklist is provided for educational purposes only. It is intended to support documentation organization and regulatory literacy and should not be interpreted as a regulatory determination, legal opinion, clinical recommendation, supplier approval, documentation certification, or product evaluation.

Supplier documentation may contribute to professional evaluation but does not independently determine regulatory classification, compliance, product suitability, or clinical appropriateness.

Scientific publications may provide educational context regarding biology, tissue science, processing, preservation, or related scientific concepts. Scientific literature does not independently determine regulatory classification.

Registration under 21 CFR Part 1271 does not constitute FDA approval, clearance, endorsement, certification, or an FDA determination regarding product safety or effectiveness.

Not By Chance Life LLC is not presented as a medical practice, treatment provider, HCT/P manufacturer, laboratory, or clinical decision-maker.